Your browser doesn't support javascript.
loading
Size-Controlled Synthesis of Gold Nanoparticles Tethering Antimicrobial Peptides with Potent Broad-Spectrum Antimicrobial and Antibiofilm Activities.
Rajchakit, Urawadee; Lamba, Saurabh; Wang, Kelvin; Lyons, Nikita; Lu, Jun; Swift, Simon; Pletzer, Daniel; Sarojini, Vijayalekshmi.
Afiliação
  • Rajchakit U; School of Chemical Sciences and The Centre for Green Chemical Science, University of Auckland, Auckland 1142, New Zealand.
  • Lamba S; The MacDiarmid Institute for Advanced Materials and Nanotechnology, Wellington 6012, New Zealand.
  • Wang K; School of Chemical Sciences and The Centre for Green Chemical Science, University of Auckland, Auckland 1142, New Zealand.
  • Lyons N; The MacDiarmid Institute for Advanced Materials and Nanotechnology, Wellington 6012, New Zealand.
  • Lu J; Auckland Bioengineering Institute, University of Auckland, Auckland 1142, New Zealand.
  • Swift S; Department of Microbiology and Immunology, University of Otago, Dunedin 9054, New Zealand.
  • Pletzer D; Auckland Bioengineering Institute, University of Auckland, Auckland 1142, New Zealand.
  • Sarojini V; Department of Molecular Medicine and Pathology, School of Medical Sciences, University of Auckland, Auckland 1142, New Zealand.
Mol Pharm ; 21(2): 596-608, 2024 Feb 05.
Article em En | MEDLINE | ID: mdl-38190605
ABSTRACT
New antimicrobials are urgently needed to combat the rising global health concern of antibiotic resistance. Antimicrobial peptides (AMPs) are one of the leading candidates as new antimicrobials since they target bacterial membranes and are therefore less prone to bacterial resistance. However, poor enzymatic stability, high production costs, and toxicity are drawbacks that limit their clinical use. Conjugation of AMPs to gold nanoparticles (NPs) may help to improve enzymatic stability and, thus, their overall antimicrobial efficiency. We did a one-pot synthesis of size-controlled (10 nm) gold NPs selectively conjugated to lipopeptides and determined their antibacterial activity. The conjugates exhibited potent (0.13-1.25 µM) antimicrobial activity against clinical isolates, including Gram-positive methicillin-resistant Staphylococcus aureus (S. aureus) ATCC33593, Gram-negative Escherichia coli (E. coli) CTX-M-14, multidrug-resistant Pseudomonas aeruginosa LESB58 and Acinetobacter baumannii ATCC19606, and showed promising activity (90% inhibition of initial biofilms and 80% reduction of preformed biofilms) against S. aureus and E. coli DH5α biofilms at low micromolar concentrations. The conjugates were stable in rat serum and not toxic to representative mammalian cell lines in vitro (≤64 µM) and in vivo (≤100 µM).
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Nanopartículas Metálicas / Staphylococcus aureus Resistente à Meticilina / Anti-Infecciosos Limite: Animals Idioma: En Revista: Mol Pharm Assunto da revista: BIOLOGIA MOLECULAR / FARMACIA / FARMACOLOGIA Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Nova Zelândia

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Nanopartículas Metálicas / Staphylococcus aureus Resistente à Meticilina / Anti-Infecciosos Limite: Animals Idioma: En Revista: Mol Pharm Assunto da revista: BIOLOGIA MOLECULAR / FARMACIA / FARMACOLOGIA Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Nova Zelândia